The full CIOC 2027 scientific program across 3 days — keynotes, oral presentations, and posters. Talks are ordered by program prominence within each day.
Day 1
- Keynote · In-Person
Long-read sequencing reveals dynamic features of human malignancies
Jianhua Luo · University of Pittsburgh School of Medicine, United States
The protein diversity of mammalian cells is determined by arrays of isoforms from genes. Genetic mutation is essential in species evolution and cancer development. Accurate Long-read transcriptome sequencing at…
- Keynote · In-Person
Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster · Brown University, United States
Nanomedicine is the use of nanomaterials to improve disease prevention, detection, and treatment which has resulted in hundreds of US FDA approved medical products. While nanomedicine has been around for several…
- Keynote · In-Person
Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers and consumers to realize the potential of genomics-informed care to secure human biosafety
Sergey Suchkov · N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
A new systems approach to diseased states and wellness result in a new branch in the healthcare ser-vices, namely, personalized and precision medicine (PPM). Meanwhile, the era of genomics-based med-icine and thus…
- Oral · In-Person
Personalized and precision medicine as a unique avenue to have the healthcare model renewed to secure national biosafety: To get cancer treated or cured?
Sergey Suchkov · N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
To achieve the implementation of Personalized & Precision Oncology (PPO), it is necessary to create a fundamentally new strategy based upon the recognition of biomarkers long before the disease clinically manifests…
- Oral · In-Person
Tumor resectability and pathologic response after neoadjuvant long-course chemoradiotherapy for locally advanced rectal cancer in a resource-limited setting
Samrawit S Halake · Kampala International University, Uganda
Purpose: In resource-limited settings, locally advanced rectal cancer (LARC) often presents at advanced stages. Long-course chemoradiotherapy (LCCRT) remains a cornerstone of neoadjuvant therapy, yet outcome data from…
- Oral · In-Person
Horizon Spectra: A comprehensive cancer genomics tertiary platform for ultra-rapid analysis
Mohammed Uddin · GenomeArc Inc, Canada
Horizon is an integrated, ultra-fast genomic intelligence platform designed to streamline and enhance precision oncology workflows. The software delivers end-to-end analytical capabilities spanning somatic and germline…
- Oral · In-Person
Reovirus inhibits tumor antigen presentation leading to impaired cytotoxic-T responses
Raghad Khaleafi · Technion-Israel Institute of Technology, Israel
Oncolytic viruses are an emerging class of cancer immunotherapies, with several agents approved for clinical use. Mammalian reovirus-based therapies are currently being evaluated in numerous clinical trials, commonly in…
- Poster · In-Person
Folate receptor-targeted nanocarrier delivery of noscapinoids for breast cancer therapy
Eeshara Naik · Sambalpur University, India
Introduction: Breast cancer remains the most prevalent malignancy among women, accounting for ~6.9% of cancer-related deaths annually, affecting 1 in 100 women. The fear of needles and the adverse effects of the current…
- Poster · In-Person
Impact of normalization strategies on the diagnostic performance of salivary microRNAs for early detection of oral squamous cell carcinoma: A systematic review, diagnostic meta-analysis, and meta-regression
Jamal Khan · Khyber College of Dentistry, Pakistan
Salivary microRNAs (miRNAs) are promising non-invasive biomarkers for the early detection of oral squamous cell carcinoma (OSCC), but variability in normalization strategies limits their reproducibility and clinical…
Day 2
- Keynote · Virtual
Precision oncology, genetic testing and gene therapy
Rajvir Dahiya · University of California San Francisco, United States
Precision oncology uses molecular and clinical information to select the most effective therapies while minimizing unnecessary toxicity. Genetic testing identifies inherited cancer predispositions and tumor-specific…
- Keynote · Virtual
Graphene quantum dots: A new frontier for photodynamic therapy
Paulo Cesar De Morais · Catholic University of Brasilia, Brazil
Fluorine-decorated graphene quantum dots (F@GQDs) will be herein explored as a material platform for application in photodynamic therapy (PDT). GQDs have been extensively studied in biomedical areas such as bioimaging…
- Oral · Virtual
A novel mechanism of mitotic spindle formation in cancer cells
Eleni Petsalaki · University of Crete, Greece
During mitosis sister chromatids are accurately segregated into two daughter cells through a microtubule-based structure known as the mitotic spindle. Mitotic spindle assembly is a crucial machinery of cell…
- Oral · Virtual
Human papillomavirus prevalence and genotype distribution among cervical cancer susceptible women of North Indian ethnicity in Gardasil vaccination era: Public health impact
Saumya Pandey · Indira IVF Hospital, India
Objectives : Human papillomavirus (HPV) is the major etiological agent of cervical cancer, a leading cause of morbidity and mortality in women worldwide; screening strategies for reducing the burden of HPV-mediated…
- Oral · Virtual
Genome-wide identification of SOX7 downstream targets and pathways in multiple myeloma through ChIP-Seq and RNA-Seq
Can Küçük · Dokuz Eylul University, Turkey
Multiple myeloma (MM) is one of the most frequent hematological malignancies. The role of transcriptionally downregulated tumor suppressor genes has not been fully characterized in MM. As a transcription factor, SOX7…
- Poster · Virtual
AI-guided optimization and structure-based virtual screening identify novel dual-state KRAS G12D inhibitor candidates
Mohamed S Khattab · Suez Canal University, Egypt
Background: KRAS G12D is one of the most prevalent oncogenic drivers in pancreatic and colorectal cancers and remains a challenging therapeutic target because of its high affinity for GTP and the absence of a reactive…
Day 3
- Keynote · Virtual
Nanoparticle-based chemiluminescent detection of an ovarian cancer biomarker – A clinically-relevant pilot study
Michael Thompson · University of Toronto, Canada
Biomarker based detection for ovarian cancer (OC) in clinical settings is currently focused on the biomarker CA-125. This marker unfortunately has a fairly low sensitivity and specificity for ovarian cancer at only 82%…
- Keynote · Virtual
Evolving concepts of breast cancer management and recent trends
Manmohan Agrawal · Pushpadi Hospital, India
The prognosis of breast cancer remains unpredictable despite of frequent change in treatment protocol since last few decades. As we understand the heterogenous nature of the disease, complex tumor biology etc. the…
- Oral · Virtual
Investigating the role of mesenchymal stem cell exosomes programmed by the breast cancer microenvironment in the rearrangement of inflammatory pathways, phenotypic changes, and interaction with immune cells in a multicellular in vitro model
Ahora Chehri · Johann Wolfgang Goethe Universität Frankfurt am, Germany
Breast cancer is widely recognized as a biologically complex disease, in large part because of its continuous and dynamic interactions with the surrounding tumor microenvironment. Among the stromal elements, mesenchymal…
- Oral · Virtual
The mathematical interpretation of breast cancer drugs
Ratan Kumar Sarkar · Independent Researcher, India
The fundamental values in the system 87 + 250 = 337 = 338(i.e. 676/2) -1 where ‘1’ is about common in the system and 900 – 676 = 224 and 676 – 224 = 452 = 561 – 109 in structural complex. In pathways, 777(lunar time)…
Present your research at CIOC 2027
Abstract submissions for the 2027 program are open · March 15–17, 2027 · Village Hotel Changi, Singapore.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.